These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 33913818)

  • 1. Development of an Emergency Department-Based Intervention to Expand Access to Medications for Opioid Use Disorder in a Medicaid Nonexpansion Setting: Protocol for Engagement and Community Collaboration.
    Walter LA; Li L; Rodgers JB; Hess JJ; Skains RM; Delaney MC; Booth J; Hess EP
    JMIR Res Protoc; 2021 Apr; 10(4):e18734. PubMed ID: 33913818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the association between specific post-overdose care services in emergency departments and subsequent treatment engagement.
    Chambers LC; Hallowell BD; Samuels EA; Daly M; Baird J; Beaudoin FL
    J Am Coll Emerg Physicians Open; 2023 Feb; 4(1):e12877. PubMed ID: 36643599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a rural emergency department-initiated buprenorphine program in the mountain west: a study protocol.
    Seliski N; Madsen T; Eley S; Colosimo J; Engar T; Gordon A; Barnett C; Humiston G; Morsillo T; Stolebarger L; Smid MC; Cochran G
    Addict Sci Clin Pract; 2024 Sep; 19(1):63. PubMed ID: 39228007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
    D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
    JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description.
    Regan S; Howard S; Powell E; Martin A; Dutta S; Hayes BD; White BA; Williamson D; Kehoe L; Raja AS; Wakeman SE
    J Addict Med; 2022 Mar-Apr 01; 16(2):216-222. PubMed ID: 34145185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency Department Access to Buprenorphine for Opioid Use Disorder.
    Herring AA; Rosen AD; Samuels EA; Lin C; Speener M; Kaleekal J; Shoptaw SJ; Moulin AK; Campbell A; Anderson E; Kalmin MM
    JAMA Netw Open; 2024 Jan; 7(1):e2353771. PubMed ID: 38285444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
    Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
    Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
    Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
    J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.
    Sue KL; Chawarski M; Curry L; McNeil R; Coupet E; Schwartz RP; Wilder C; Tsui JI; Hawk KF; D'Onofrio G; O'Connor PG; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2023 May; 6(5):e2312718. PubMed ID: 37163263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial of an emergency department-based peer recovery support intervention to increase treatment uptake and reduce recurrent overdose among individuals at high risk for opioid overdose: study protocol for the navigator trial.
    Goedel WC; Marshall BDL; Samuels EA; Brinkman MG; Dettor D; Langdon KJ; Mahoney LA; Merchant RC; Nizami T; O'Toole GA; Ramsey SE; Yedinak JL; Beaudoin FL
    BMJ Open; 2019 Nov; 9(11):e032052. PubMed ID: 31719087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race, ethnicity, and emergency department post-overdose care.
    Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
    J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of an emergency department peer navigator (EDPN) program in improving clinical outcomes and healthcare utilization in an urban setting.
    Santos C; Ramdin C; Becceril J; Al Kik B; Jefri M; Nelson L
    Am J Emerg Med; 2023 Jun; 68():10-16. PubMed ID: 36905880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial.
    Melnick ER; Jeffery MM; Dziura JD; Mao JA; Hess EP; Platts-Mills TF; Solad Y; Paek H; Martel S; Patel MD; Bankowski L; Lu C; Brandt C; D'Onofrio G
    BMJ Open; 2019 May; 9(5):e028488. PubMed ID: 31152039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.
    D'Onofrio G; Hawk KF; Herring AA; Perrone J; Cowan E; McCormack RP; Dziura J; Taylor RA; Coupet E; Edelman EJ; Pantalon MV; Owens PH; Martel SH; O'Connor PG; Van Veldhuisen P; DeVogel N; Huntley K; Murphy SM; Lofwall MR; Walsh SL; Fiellin DA
    Contemp Clin Trials; 2021 May; 104():106359. PubMed ID: 33737199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.
    Martin A; Butler K; Chavez T; Herring A; Wakeman S; Hayes BD; Raja A
    West J Emerg Med; 2020 Nov; 21(6):257-263. PubMed ID: 33207174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peer Intervention to Link Overdose Survivors to Treatment (PILOT): Protocol for a Multisite, Randomized Controlled Trial Conducted Within the National Institute on Drug Abuse Clinical Trials Network.
    Papa C; McClure EA; McCauley J; Haynes L; Matheson T; Jones R; Jennings L; Lawdahl T; Ward R; Brady K; Barth KS
    JMIR Res Protoc; 2024 Sep; 13():e60277. PubMed ID: 39288373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.